JHLT: The Podcast – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

JHLT: The Podcast

ISHLT

Science

Frequency: 1 episode/23d. Total Eps: 91

The Journal of Heart and Lung Transplantation podcast airs each month and features the JHLT Digital Media Editors in round table talks with the Journal's contributors.

Site

RSS

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

No recent rankings available

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://www.jhltonline.org/article/S1053-2498
136 shares
http://www.jhltonline.org/current
85 shares
https://www.jhltonline.org/
82 shares

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 62%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Episode 72: Impact of Donor-Specific Antibodies on Longitudinal Lung Function and BLAD

Season 5 · Episode 17

Wednesday, November 5, 2025 • Duration 19:54

On this episode of JHLT: The Podcast, the Digital Media Editors host a discussion on the paper, "Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction."

They are joined by the first author, Muhtadi Alnababteh, MD, Assistant Professor at the University of Maryland and Staff Clinician at the National Institutes of Health, and senior author Michael Keller, MD, of the Pulmonary and Critical Care division at the University of Maryland.

The discussion explores:

Common characteristics of patients who developed donor-specific antibodies (DSA)
Differences in outcomes depending on when DSA developed
Associations between the development of DSA and antibody-mediated rejection, and related time frames

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Read moreCollapse

Episode 71: Cardiogenic Shock Working Group: Patients on Impella 5.5 for more than 14 days

Season 5 · Episode 16

Wednesday, October 15, 2025 • Duration 21:09

On this episode of JHLT: The Podcast, the Digital Media Editors invite co-lead author Nir Uriel, MD, Director of Advanced Heart Failure and Cardiac Transplantation at New York Presbyterian Hospital and Professor of Medicine at Columbia University.

Dr. Uriel joins to discuss the work of the Cardiogenic Shock Working Group (CSWG) and their recent paper, "Outcomes of patients supported on Impella 5.5 for more than 14 days: A Cardiogenic Shock Working Group registry analysis."

The discussion explores:

Why patients on longer duration of MCS had better survival but maintained similar rates of serious adverse events (SAEs)
Why the study might show fewer SAEs than the literature historically shows
How temporary MCS devices are selected in clinical settings in patients with cardiogenic shock
The ongoing and upcoming activities of CSWG

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Read moreCollapse

Episode 62: Apixaban Plasma Levels in Patients with HeartMate 3

Season 5 · Episode 7

Thursday, April 10, 2025 • Duration 12:40

Returning for a second study this month, the JHLT Digital Media Editors invite first author Charlotte Van Edom to discuss the paper, "Apixaban plasma levels in patients with HeartMate 3 support."

As a cardiologist in training and a PhD candidate at the University Hospitals Leuven in Belgium, Van Edom's work focuses on hemocompatibility and mechanical circulatory support, covering both short-term and long-term support.

The episode explores:

The evolution of the use and understanding of direct oral anticoagulants (DOACs) during LVAD support, including the increased focus on Factor Xa inhibitors
Encouraging findings from the study and what clinical practices might need to change if introducing apixaban
Additional studies exploring DOACs in LVAD patients

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Treat or research pulmonary vascular diseases? Check out the first April episode for a study on sotatercept in PAH patients.

Read moreCollapse

Episode 61: Is Sotatercept safe in patients with PAH?

Season 5 · Episode 6

Wednesday, April 2, 2025 • Duration 13:00

On this episode of JHLT: The Podcast, the Digital Media Editors invite author Ioana Preston, MD, to discuss the paper, "Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR."

Dr. Preston is the director of the pulmonary hypertension center at Lahey Hospital and Medical Center in Burlington, Massachusetts, and has over 20 years of experience in caring for patients with PH, as well as multiple clinical trials in PH.

The episode explores:

What makes sotatercept unique as the first "biologic" in the treatment of PAH
Hypotheses about the mechanism of action in sotatercept
Sotatercept's interaction with mPAP and what it indicates about the drug's action on the pulmonary vasculature

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those involved in the heart failure and mechanical circulatory support should tune in again later this month for a study on apixaban plasma levels in patients with HeartMate 3 support.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at .

Episode 60: Riociguat in patients with PAH and Cardiometabolic Comorbidities

Season 5 · Episode 6

Tuesday, March 18, 2025 • Duration 07:19

Returning for a second study this month, the JHLT Digital Media Editors conduct an internal discussion on the paper, "Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials."

The episode explores:

The aging PAH population and the new comorbidities that must be considered in research
How the study augments and expands on recent standards, like the 2022 ESC/ERS guidelines for pulmonary hypertension
Limitations on the study and opportunities for future research

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those on lung transplant teams should check the previous episode for a study on how rewarming ischemia time affects lung transplant outcomes.

Read moreCollapse

Episode 59: Rewarming Ischemia Time in Lung Transplantation

Season 5 · Episode 5

Wednesday, March 5, 2025 • Duration 13:36

On this episode of JHLT: The Podcast, the Digital Media Editors invite lead author Jan Van Slambrouck, MD, to discuss the paper, "The effect of rewarming ischemia on tissue transcriptome and metabolome signatures: A clinical observational study in lung transplantation."

Dr. Van Slambrouck is a general surgeon who's just finished his PhD training at the KU Leuven lab of respiratory disease and thoracic surgery in Belgium.

The episode explores:

How rewarming ischemia time (RIT) affects donor lungs, especially on the molecular level
The pace of rewarming and how prior literature prepared the team to track and evaluate it
Clinical strategies to reduce RIT and directly address molecular changes

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those involved in the pulmonary vascular disease space should tune in again later this month for a study on the safety and efficacy of riociguat in patients with PAH.

Episode 58: Sympathetic Reinnervation

Season 5 · Episode 4

Thursday, February 20, 2025 • Duration 12:45

Returning for a second study this month, the JHLT Digital Media Editors invite lead author Oliver J.F. Weiner, to discuss the paper, "Sympathetic reinnervation in cardiac transplant recipients: Prevalence, time course, and association with long-term survival."

Dr. Weiner is currently an out of training registrar at Monash Health in Melbourne, Australia, but will soon return to his home of the UK to begin internal medicine training with the intention becoming a cardiologist. He is especially interested in advanced heart failure and electrophysiology.

The episode explores:

The uncertainty around clinical influences on reinnervation
The importance of this single-center study in expanding the literature
Potential future treatment options

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those on lung transplant teams should check the previous episode for a study on recent trends and post-transplant outcomes from EVLP.

Read moreCollapse

Episode 57: Trends and Outcomes in EVLP

Season 5 · Episode 3

Wednesday, February 5, 2025 • Duration 12:22

On this episode of JHLT: The Podcast, the Digital Media Editors invite lead author Jonathan E. Williams, MD, to discuss the paper, "Ex-Vivo Lung Perfusion: National Trends and Post-Transplant Outcomes."

Dr. Williams is a general surgery resident at the University of Michigan in Ann Arbor, with work focusing on contemporary lung preservation strategies, perfusion techniques, and particularly, EVLP.

The episode explores:

How the study explores the theory that EVLP use may increase transplant volumes
Preserving data quality and other study limitations
How to work in fields of study that sometimes yield as many questions as answers

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those on heart transplant teams should tune in again later this month for a study on sympathetic reinnervation in cardiac transplant recipients.

Read moreCollapse

Episode 56: The Best Studies of 2024

Season 5 · Episode 2

Thursday, January 16, 2025 • Duration 11:51

JHLT: The Podcast returns with a year-end recap of 2024. Each Digital Media Editor shares one of their favorite studies from JHLT in 2024 for a quick recap of last year's excellent science in advanced heart and lung disease.

Studies featured:

· Cardiac magnetic resonance assessment of acute rejection and cardiac allograft vasculopathy in pediatric heart transplant
Kikano, Sandra et al. JHLT May 2024 5(43):745-754

· A modular simulation framework for organ allocation
Rose, Johnie et al. JHLT Aug 2024 8(43):1326-1335.

· HeartMate 3 Snoopy: Noninvasive cardiovascular diagnosis of patients with fully magnetically levitated blood pumps during echocardiographic speed ramp tests and Valsalva maneuvers
Schlöglhofer, Thomas et al. JHLT Feb 2024 2(43):251-260.

· Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group
Kochar, Ajar et al. JHLT Nov 2024 11(43):1846-1856.

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at for a free subscription, or subscribe today at .

Episode 55: Meet the Editors!

Season 5 · Episode 1

Wednesday, January 8, 2025 • Duration 16:21

Happy new year from JHLT: The Podcast! On this episode, the Digital Media Editors are joined by ISHLT Director of Marketing + Communications Jess Burke, CAE, to share a little bit about themselves and their backgrounds.

Hear about how each of the JHLT Digital Media Editors got involved in transplantation and a little about each of their research and personal interests.

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Read moreCollapse

JHLT: The Podcast – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

JHLT: The Podcast – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

Other57

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Other57

Related Shows Based on Content Similarities